Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ecupharma is a private Italian pharmaceutical company based in Milan that specializes in the Central Nervous System (CNS) and Urology therapeutic areas. Founded in 1993, the company has established a strong presence in the Italian market by partnering with global pharmaceutical entities to license and commercialize innovative treatments. Their portfolio includes therapies for Parkinson's disease, epilepsy, and various urological conditions, as well as a growing focus on rare diseases. Ecupharma provides comprehensive services including regulatory support, marketing, and a specialized sales network to ensure patient access to critical medications. The company's business model focuses on value-added medicines and strategic alliances to address unmet medical needs in specialized clinical settings. With a dedicated focus on the Italian healthcare landscape, Ecupharma continues to expand its reach through the acquisition of product rights and internal development projects.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ECUPHARMA.